mediproCan® Pharma GmbH
mediproCan® Pharma GmbH is a German GMP and GDP certified manufacturer, importer, and wholesaler of medical cannabis flowers and extracts, headquartered in Neumünster. It sells through pharmaceutical wholesalers, licensed pharmacies, and a DocCheck-secured B2B webshop serving the German prescription market, with the Juwel and Gloweed product lines.
- Company typePrivate
- Founded1984
- HeadquartersNeumünster, Germany
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What mediproCan® Pharma GmbH does
mediproCan® Pharma GmbH is a privately held German pharmaceutical manufacturer, importer, and wholesaler of medical cannabis, headquartered in Neumünster (Memellandstr. 2, 24537) and operating under the supervisory authority of the Landesamt für soziale Dienste des Landes Schleswig-Holstein. The company holds GMP (Good Manufacturing Practice) and GDP (Good Distribution Practice) certifications and produces cannabis flowers and extracts under strict pharmaceutical quality guidelines ensuring consistent composition and concentration of active ingredients. Leadership comprises Managing Directors Felix Kühl and Dr. Martin Haase, with Anna Kühl as CMO. The company claims 40 years of pharmaceutical industry experience, dating its heritage to 1984, though its cannabis-focused commercial activity began only in April 2023 with the launch of the "Juwel" premium flower line, followed in October 2024 by the "Gloweed" craft sub-brand debuting the MYKONOZ strain.
The company operates a sales-led, B2B go-to-market model. Revenue mechanics flow through three distribution layers: pharmaceutical wholesalers, licensed pharmacies dispensing against prescriptions, and a DocCheck-authenticated webshop for healthcare professional ordering — all serving the German medical cannabis market under §31 Paragraph 6 SGB V. Pricing is not publicly disclosed, and products are prescription-only and subject to German narcotics law. The company has no disclosed external investors, no parent company, and no disclosed funding rounds despite operating an "Investoren" page that signals future capital intent.
The underlying technology is conventional pharmaceutical manufacturing adapted to a regulated botanical input — no proprietary software platform, AI/ML systems, or data flywheel mechanics are evidenced. Marketing and customer engagement are conducted through the corporate website, LinkedIn and Instagram presence, and participation in industry fairs and events. With only 5 disclosed employees, the operation is small relative to its GMP-certified manufacturing footprint, suggesting a high-leverage model dependent on a narrow set of channel partners.
mediproCan® Pharma GmbH firmographics
Firmographics- Name
- mediproCan® Pharma GmbH
- Legal name
- mediproCan Pharma GmbH
- Website
- https://mediprocan.com
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- mediproCan® Pharma GmbH is a German GMP and GDP certified manufacturer, importer, and wholesaler of medical cannabis flowers and extracts, headquartered in Neumünster. It sells through pharmaceutical wholesalers, licensed pharmacies, and a DocCheck-secured B2B webshop serving the German prescription market, with the Juwel and Gloweed product lines.
- Ownership category
- akta.pro rank
mediproCan® Pharma GmbH industry classification
Industry- Product category
- Medical Cannabis Pharmaceuticals
- NAICS
- Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
- akta.pro secondary industry
- Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG)
Keywords
Where mediproCan® Pharma GmbH is headquartered
LocationHeadquarters
- HQ city
- Neumünster
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
mediproCan® Pharma GmbH business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Medical Cannabis Products: Manufacturing and distribution of medical cannabis flowers and extracts to wholesalers, pharmacies, and healthcare providers in the German market. Products include premium cannabis strains with different THC contents.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
mediproCan® Pharma GmbH product offering
Product offeringCore offering
mediproCan® Pharma GmbH is a German GMP and GDP certified manufacturer, importer, and wholesaler of medical cannabis. The company produces and distributes pharmaceutical-grade cannabis flowers and extracts, including its premium Juwel product line and the Gloweed craft sub-brand, selling to wholesalers, licensed pharmacies, and healthcare professionals in Germany. The company controls the full supply chain from development through production to logistics, ensuring consistent composition and concentration of active ingredients.
Differentiator
Problem solved
Functional benefit
Brands
- Gloweed: Premium sub-brand featuring high-quality craft cannabis strains. Launched as part of mediproCan's entry into the craft cannabis market segment.
Products and services
- Juwel Premium Cannabis Flower Line Premium product line of medical cannabis flowers offered in multiple strains with varying THC contents, launched in April 2023 as the company's market entry. Sold through wholesalers, pharmacies, and healthcare professionals in Germany for prescription dispensing to patients with qualifying conditions under §31 Paragraph 6 SGB V.
- Gloweed Premium Craft Sub-Brand Premium sub-brand of mediproCan® featuring high-quality craft cannabis strains with unique terpene profiles, targeting patients who appreciate refined cannabis experiences. Sold to wholesalers, pharmacies, and healthcare professionals in Germany under prescription channels.
- MYKONOZ Craft Cannabis Strain First craft cannabis strain under the Gloweed sub-brand, containing 23% THC, with a rich terpene profile, grown indoors in Canada using 'living soil' cultivation methods, available in limited small batches for the German medical cannabis market.
- Medical Cannabis Flowers and Extracts Portfolio German GMP and GDP certified product portfolio of medical cannabis flowers and extracts, manufactured and distributed to wholesalers, pharmacies, and healthcare providers for patients with serious medical conditions including chronic pain, sleep disorders, psychiatric disorders (AD(H)S, anxiety, depression, PTSD), neurological diseases (migraine, multiple sclerosis, epilepsy), gastrointestinal diseases, skin diseases, cancer symptoms, and menstrual/endocrine conditions.
Companies that use mediproCan® Pharma GmbH
Customer profileSegments3 records
Ideal customer profiles3 records
mediproCan® Pharma GmbH technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
mediproCan® Pharma GmbH partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights4 records
mediproCan® Pharma GmbH competitors and assessment
Company assessmentRegional players
- Four20 Pharma: Four20 Pharma is a German pharmaceutical company specializing in medical cannabis products, distributing cannabis flowers and extracts to German pharmacies. Comparable as a German-focused GMP-certified medical cannabis supplier.
Direct peers
- Demecan: Demecan is a German GMP-certified producer and distributor of medical cannabis, headquartered in Berlin. It is the closest direct competitor to mediproCan in the German medical cannabis wholesale and pharmacy channel.
- Bedrocan: Bedrocan is a Dutch GMP-certified medical cannabis producer that has historically been a major supplier to the German market. Comparable to mediproCan as a pharma-grade cannabis manufacturer/wholesaler serving German pharmacies.
- Cannamedical Pharma: Cannamedical is a German pharmaceutical company importing and distributing medical cannabis flowers and extracts to German pharmacies. Comparable to mediproCan in both the GMP-certified wholesale model and the pharmacy-channel go-to-market.
- Sanity Group: Sanity Group is a Berlin-based medical cannabis company operating across cultivation, manufacturing, and distribution in Germany. It directly overlaps with mediproCan in the German pharmacy-supply channel.
Broad incumbents
- Aphria (now part of Tilray): Aphria (now under Tilray) is a Canadian cannabis producer with European supply operations. Comparable as a GMP-certified medical cannabis wholesaler serving the German market, though it operates at significantly larger scale.
- Canopy Growth Corporation: Canopy Growth operates a broad medical cannabis portfolio with German-market presence through its Stada-branded distribution. Comparable as a large-scale GMP-certified medical cannabis supplier competing in the same pharmacy channel as mediproCan.
- Aurora Cannabis: Aurora Cannabis is a Canadian licensed producer with European operations including Germany. Comparable as a GMP-certified medical cannabis wholesaler in Germany, but materially larger and more diversified.
- STADA Arzneimittel AG: STADA is a major German generics and specialty pharma company active in medical cannabis distribution through partnerships. Comparable to mediproCan as a German-headquartered pharma partner with medical cannabis offerings, though far larger and broader.
- Tilray Medical: Tilray is a globally scaled Canadian medical cannabis producer with significant German distribution. It competes with mediproCan in the German pharmacy channel but is a much broader incumbent with global operations.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
mediproCan® Pharma GmbH social profiles
Digital presencemediproCan® Pharma GmbH financial estimates
Financial estimateRevenue estimate
Valuation estimate
mediproCan® Pharma GmbH leadership team
Management profileNumber of profiles
Profiles3 records
mediproCan® Pharma GmbH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
mediproCan® Pharma GmbH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about mediproCan® Pharma GmbH
What does mediproCan® Pharma GmbH do?
mediproCan® Pharma GmbH is a German GMP and GDP certified manufacturer, importer, and wholesaler of medical cannabis. The company produces and distributes pharmaceutical-grade cannabis flowers and extracts, including its premium Juwel product line and the Gloweed craft sub-brand, selling to wholesalers, licensed pharmacies, and healthcare professionals in Germany. The company controls the full supply chain from development through production to logistics, ensuring consistent composition and concentration of active ingredients.
Is mediproCan® Pharma GmbH a public or private company?
mediproCan® Pharma GmbH is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was mediproCan® Pharma GmbH founded?
mediproCan® Pharma GmbH was founded in 1984. It employs 1 to 10 people.
Where is mediproCan® Pharma GmbH based?
mediproCan® Pharma GmbH is headquartered in Neumünster, Germany, in the Europe region.
How does mediproCan® Pharma GmbH make money?
One revenue line is on record: medical Cannabis Products.
Who are mediproCan® Pharma GmbH's main competitors?
Four20 Pharma is listed as a regional player. Direct peers are Demecan, Bedrocan, Cannamedical Pharma and Sanity Group. Broad incumbents are Aphria (now part of Tilray), Canopy Growth Corporation, Aurora Cannabis, STADA Arzneimittel AG and Tilray Medical.
Does mediproCan® Pharma GmbH have an API?
No public API is recorded for mediproCan® Pharma GmbH.
What industry is mediproCan® Pharma GmbH in?
mediproCan® Pharma GmbH's product category is Medical Cannabis Pharmaceuticals. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of CRANAFAG, Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail). Its NAICS code is 325411 and its SIC code is 2833.